Ambar Bhattacharyya is a vice president in BVP's Cambridge, MA office. He focuses on investments in early- and growth-stage healthcare and education companies and has been closely involved in Bessemer's investments in Verastem (IPO), OvaScience, Liazon, Fractyl Laboratories, Health Essentials and Accuvein. He is also actively involved in BVP's investments in Cerulean and Oxagen. Prior to joining Bessemer, Ambar worked as an associate at Bain Capital Ventures. There, he helped make investments in companies such as Ameritox, Accelecare, LinkedIn (IPO), iPay Technologies (acq. by Jack Henry), TargetSpot, and VMLogix (acq. by Citrix). Before Bain Capital, Ambar was the assistant to the CEO at MinuteClinic, a company that runs health clinics staffed by nurse practitioners inside retail settings and was acquired by CVS. He began his career at Bain and Co. where he worked on projects across various industries, including healthcare, business services and technology, as well as for non-profit clients at The Bridgespan Group. After attending business school, Ambar interned with the City of Fremont, CA, where he helped the city develop its clean-tech strategy.Ambar holds an MBA with distinction from Harvard Business School and a B.S. in economics and a B.A. in psychology from the University of Pennsylvania, where he graduated magna cum laude. He currently is the co-Chair of New England Venture Network (NEVN). Ambar also serves on the Board of UP Academy of Boston, an in-district turnaround charter school. In 2012, he was selected by the World Economic Forum as a Global Shaper, a group of leaders under the age of 30 charged with catalyzing positive social change in their respective communities. Ambar regularly blogs at HcVCs.com.

Business, Education Professionals, Entrepreneurship, Medicine, Education Industry, Education, Economy Finance,